Replies to post #137154 on Innovation Pharmaceuticals Inc (IPIX)

[noretreat]

Well, I hope that the ovarian phase 2 trial can start this year. I also hope to see an article published this year, but I don't think that is going to be a major impact. It seems to me that DF is still looking for clearer results. Safety, the primary objective of phase 1, is no longer a question.